May 31, 2022 Acad, Gov/Utilities FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA) Read more
May 27, 2022 Clinical Research/Diagn. Product Launch New pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma Read more
May 27, 2022 Clinical Research/Diagn. Product Launch New pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma Read more
May 25, 2022 Uncategorized Roche’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma Read more
May 25, 2022 Life Science Tools Roche develops unique PCR tests to detect the monkeypox virus Read more
May 25, 2022 Life Science Tools Roche develops unique PCR tests to detect the monkeypox virus Read more
May 24, 2022 Clinical Research/Diagn. Data at the 2022 ASCO Annual Meeting highlight Roche’s continued commitment to innovation in oncology and personalised healthcare Read more
May 24, 2022 Clinical Research/Diagn. Data at the 2022 ASCO Annual Meeting highlight Roche’s continued commitment to innovation in oncology and personalised healthcare Read more
May 24, 2022 Clinical Research/Diagn. Data at the 2022 ASCO Annual Meeting highlight Roche’s continued commitment to innovation in oncology and personalised healthcare Read more
May 12, 2022 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure Read more
